Cirrhosis, antibodies increase risk of poor outcome for autoimmune hepatitis patients
(Wiley) New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen/liver pancreas antigen are major risk factors for poor short- and long-term outcome in patients with autoimmune hepatitis.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Cirrhosis | Health | Hepatitis | International Medicine & Public Health | Liver | Pancreas | Urology & Nephrology